Parisa Farzam, PhD. Banner for Monday, November 23rd, MIT Sloan Health Systems Initiative ( HSI ) Lunch Series: Incentives Eat Algorithms: The Hidden Economics of AI Adoption in Life Sciences with Parisa Farzam, PhD

Monday, November 23rd, MIT Sloan Health Systems Initiative (HSI) Lunch Series: Incentives Eat Algorithms: The Hidden Economics of AI Adoption in Life Sciences with Parisa Farzam, PhD

by

Seminar AI Data Analytics Economics Health Systems Healthcare Healthcare Delivery Life Sciences

Mon, Nov 23, 2026

11:30 AM – 1 PM EST (GMT-5)

E62-350

100 Main Street, Cambridge, MA United States

2
Registered

Registration

Options Sales Start Sales End Availability Price
Option RSVP in person, lunch provided

Sales Start Sep 30, 2026 at 12 PM Sales End Nov 23, 2026 at 11 AM Availability Unlimited Price FREE
Option RSVP on Zoom

Sales Start Sep 30, 2026 at 12 PM Sales End Nov 23, 2026 at 11 AM Availability Unlimited Price FREE

Details

MIT Sloan Health Systems Initiative (HSI) Lunch Series: Incentives Eat Algorithms: The Hidden Economics of AI Adoption in Life Sciences with Parisa Farzam, PhD

Monday, November 23
11:30am - 1pm 
E62 - 350
On Zoom
Lunch provided

AI models for health care and life sciences have never been stronger. They read scans, document clinical encounters, design molecules and raise productivity. Yet most never make it into routine use. In this talk, we take a close look at the economics of adoption and the work-value gap: the misalignment between those who bear the cost and effort of adopting AI and those who capture the value it creates. We close with early examples of how health systems, payers and life sciences companies have started to narrow it.

Parisa Farzam, PhD, is co-founder and CEO of Oxyverse, a platform for monitoring brain function in neurocritical care, and a Blavatnik Fellow at Harvard Business School. Previously, she led AI products in healthcare and life sciences at Bayer and IBM, taking them from development through launch and strategic partnerships. Across nearly two decades spanning clinical settings, Big Tech and pharma, she has focused on what it takes to move AI from technical promise to sustained use.

CEO & Co-founder, Oxyverse | Blavatnik Fellow, Harvard Business School

Any questions contact Lisa Maloney lmaloney@mit.edu

Speakers

Parisa Farzam, PhD's profile photo

Parisa Farzam, PhD

CEO & Co-founder

Oxyverse

https://www.linkedin.com/in/parisafarzam

Parisa Farzam, PhD, is co-founder and CEO of Oxyverse, a platform for monitoring brain function in neurocritical care, and a Blavatnik Fellow at Harvard Business School.

Previously, she led AI products in healthcare and life sciences at Bayer and IBM, taking them from development through launch and strategic partnerships. Across nearly two decades spanning clinical settings, Big Tech and pharma, she has focused on what it takes to move AI from technical promise to sustained use.

“Ana“ Anne Quaadgras's profile photo

"Ana" Anne Quaadgras

Director

MIT Sloan Health Systems Initiative

https://www.linkedin.com/in/anne-quaadgras-6208778/

Is the Director of the MIT Sloan Health Systems Initiative and a Senior Lecturer at MIT Sloan.

Her work focuses on health systems transformation, and the role of information technology in supporting that change.


Prior to her doctoral work, Anne was a management consultant for fifteen years, specializing in improving decision-making and investment processes in the chemical, pharmaceutical, and financial services industries.

She holds a Bachelor’s and Master’s degree in chemical engineering from MIT. Anne earned her doctorate in information systems at Boston University, where her dissertation research explored how globally distributed groups of experts recognize and respond to operational problems.


Hosted By

Health Systems Initiative | Website | View More Events